摘要: At least 2 million persons succumb annually to enteric infection, and in countless other patients, diarrheal disease aggravates malnutrition susceptibility infections. Prevention of illness by virtue improved hygiene provision sanitation water treatment is impractical most developing countries, where morbidity mortality rates are highest. For this reason, development vaccines against the important gastrointestinal infections remains a high priority.
elsevier.com
sci-hub.se 参考文章(102)
H. F. Clark, P. A. Offit, R. W. Ellis, D. Krah, A. R. Shaw, J. J. Eiden, M. Pichichero, J. J. Treanor, WC3 reassortant vaccines in children. Archives of virology. Supplementum. ,vol. 12, pp. 187- 198 ,(1996) , 10.1007/978-3-7091-6553-9_20
A.-M. Svennerholm, N. Lycke, J. Holmgren, C. Czerkinsky, Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. American Journal of Tropical Medicine and Hygiene. ,vol. 50, pp. 42- 54 ,(1994)
J. Holmgren, A.-M. Svennerholm, Vaccines Against Diarrheal Diseases Handbook of experimental pharmacology. ,vol. 133, pp. 291- 328 ,(1999) , 10.1007/978-3-642-59955-2_12
Joseph S Bresee, Roger I Glass, Bernard Ivanoff, Jon R Gentsch, Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries1Prepared as a review for the Consensus Workshop on Rotavirus Vaccines for use in Developing Countries, Geneva, January 9–10, 1997. Sponsored by: The Global Programme for Vaccines, World Health Organization, The Children's Vaccine Initiative and the Centers for Disease Control and Prevention.1 Vaccine. ,vol. 17, pp. 2207- 2222 ,(1999) , 10.1016/S0264-410X(98)00376-4
Jie Yu, William H.R. Langridge, A plant-based multicomponent vaccine protects mice from enteric diseases Nature Biotechnology. ,vol. 19, pp. 548- 552 ,(2001) , 10.1038/89297
C O Tacket, M B Sztein, G A Losonsky, S S Wasserman, J P Nataro, R Edelman, D Pickard, G Dougan, S N Chatfield, M M Levine, Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infection and Immunity. ,vol. 65, pp. 452- 456 ,(1997) , 10.1128/IAI.65.2.452-456.1997
Lanfong H. Lee, Edward Burg, Shahida Baqar, A. L. Bourgeois, Don H. Burr, Cheryl P. Ewing, Trevor J. Trust, Patricia Guerry, Evaluation of a Truncated Recombinant Flagellin Subunit Vaccine against Campylobacter jejuni Infection and Immunity. ,vol. 67, pp. 5799- 5805 ,(1999) , 10.1128/IAI.67.11.5799-5805.1999
C O Tacket, D M Hone, R Curtiss, S M Kelly, G Losonsky, L Guers, A M Harris, R Edelman, M M Levine, Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infection and Immunity. ,vol. 60, pp. 536- 541 ,(1992) , 10.1128/IAI.60.2.536-541.1992
D N Taylor, A C Trofa, J Sadoff, C Chu, D Bryla, J Shiloach, D Cohen, S Ashkenazi, Y Lerman, W Egan, Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infection and Immunity. ,vol. 61, pp. 3678- 3687 ,(1993) , 10.1128/IAI.61.9.3678-3687.1993
G Losonsky, O Castro, J Gutierrez, R Meza, J P Nataro, J B Kaper, S S Wasserman, R Edelman, M M Levine, S J Cryz, D N Taylor, C O Tacket, Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru. Infection and Immunity. ,vol. 65, pp. 3852- 3856 ,(1997) , 10.1128/IAI.65.9.3852-3856.1997